CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 95 filers reported holding CTI BIOPHARMA CORP in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $22,000 | +37.5% | 52,768 | +25.1% | 0.00% | – |
| Q3 2016 | $16,000 | -40.7% | 42,164 | -47.3% | 0.00% | – |
| Q2 2016 | $27,000 | -99.2% | 80,061 | -98.7% | 0.00% | -100.0% |
| Q1 2016 | $3,212,000 | -54.7% | 6,043,618 | +4.8% | 0.00% | -50.0% |
| Q4 2015 | $7,092,000 | +13.2% | 5,766,088 | +34.4% | 0.00% | 0.0% |
| Q3 2015 | $6,264,000 | -24.2% | 4,290,232 | +1.2% | 0.00% | 0.0% |
| Q2 2015 | $8,268,000 | +8.8% | 4,239,943 | +1.0% | 0.00% | 0.0% |
| Q1 2015 | $7,598,000 | -22.7% | 4,197,699 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $9,827,000 | +24.8% | 4,163,937 | +28.0% | 0.00% | 0.0% |
| Q3 2014 | $7,872,000 | -16.5% | 3,252,712 | -3.1% | 0.00% | -33.3% |
| Q2 2014 | $9,429,000 | – | 3,355,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 10,698,618 | $13,159,000 | 15.42% |
| BVF INC/IL | 43,795,613 | $53,869,000 | 9.18% |
| DAFNA Capital Management LLC | 3,195,381 | $3,930,000 | 3.50% |
| Sio Capital Management, LLC | 5,292,262 | $6,509,000 | 2.88% |
| NEXTHERA CAPITAL LP | 656,000 | $807,000 | 1.14% |
| Lombard Odier Asset Management (USA) Corp | 1,357,456 | $1,670,000 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,236,832 | $2,751,000 | 0.11% |
| Consonance Capital Management LP | 510,000 | $635,000 | 0.08% |
| Candriam S.C.A. | 1,515,000 | $1,863,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 575,669 | $708,000 | 0.04% |